Actimmune
What is actimmune®?
Actimmune® is a bioengineer protein sanctioned by the FDA for discussion of certain diseases. The protein, a form of interferon gamma, affects the immune system. Actimmune® also is approved for covering malignant osteopetrosis. Treatment often happens in conjunction with antibiotics. These recurring infections result in chronic granulomas, or areas of inflammation, in impressed areas, which often include the lungs and spleen. Actimmune® can be used to treat both adults and children suffering from this disorder. Though mild cases produce few symptoms, more intense cases can lead to increased frequency of communications because of a reduction in the size of the bone marrow.
A bone marrow transfer is the only known change for osteopetrosis, although Actimmune® has been demonstrated to slow progression of the disease. Slowing the disease can be particularly important in cases of malignant osteopetrosis, because it can take time to find an appropriate donor for a bone marrow transplant. Other drugs also have shown a slowing effect on osteopetrosis, but Actimmune® was the first drug with FDA approval for this treatment.
Looking for anything Else ? Try Our Search
